Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?-Reference-Cited by-同舟云学术

Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?

Published:2022-05-17 Issue:7 Volume:37 Page:1346-1359
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Engelender Simone¹,Stefanis Leonidas²³,Oddo Salvatore⁴,Bellucci Arianna⁵^ORCID

Affiliation:

1. Department of Biochemistry, The B. Rappaport Faculty of Medicine and Institute of Medical Research Technion‐Israel Institute of Technology Haifa Israel

2. Biomedical Research Foundation of the Academy of Athens Athens Greece

3. First Department of Neurology National and Kapodistrian University of Athens Medical School Athens Greece

4. Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences University of Messina Messina Italy

5. Department of Molecular and Translational Medicine University of Brescia Brescia Italy

Funder

H2020 Marie Skłodowska-Curie Actions

Horizon 2020 Framework Programme

Michael J. Fox Foundation for Parkinson's Research

Multiple System Atrophy Coalition

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29058

Reference87 articles.

1. Molecular pathology of neurodegenerative diseases: principles and practice

2. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

3. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

4. The role of connectivity and neuronal phenotype in determining the pattern of α‐synuclein pathology in Parkinson's disease;Henderson MX;Neurobiol Dis,2022

5. The Threshold Theory for Parkinson's Disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The αSynuclein half-life conundrum;Neurobiology of Disease;2024-06

2. Association between Parkinson’s Disease and Cancer: New Findings and Possible Mediators;International Journal of Molecular Sciences;2024-03-31

3. The contribution of β-amyloid, Tau and α-synuclein to blood–brain barrier damage in neurodegenerative disorders;Acta Neuropathologica;2024-02-12

4. Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation;Autophagy;2023-11-22

5. Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?;Frontiers in Molecular Neuroscience;2023-05-25